Mehta Vimal
CIK 0001733369
CEO and PresidentDirector10% Owner
Filings
26
Latest May 22, 2026
Issuers covered
1
Showing
26 of 26
Page 1
Track record
24 of 25 open-market trades scored (96% price coverage) - 1 issuer without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 24 | 75% | +18.5% | +14.5% | +50.1% | -11.6% |
| 90 days | 24 | 75% | +48.3% | +62.0% | +84.7% | -5.4% |
| 180 days | 24 | 100% | +79.5% | +81.2% | +85.3% | +69.5% |
| 365 days | 24 | 100% | +88.0% | +92.8% | +96.2% | +70.8% |
Issuers
Companies where Mehta Vimal has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| BTAI | Bioxcel Therapeutics, Inc. | 26 | May 22, 2026 |
All filings
26 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|